Table 3 Clinicopathological correlation with KIAA1549-BRAF fusion status in patients with LGG
From: Incidence of kiaa1549-braf fusion gene in Egyptian pediatric low grade glioma
Total | Positive | Negative | p-value | |
|---|---|---|---|---|
Tumor examined | 60 | 34(56.6%) | 26(43.3%) | |
Tumor location | ||||
Cerebellar | 37(61%) | 26(70.2%) | 11(29.2%) | 0.008* |
Lobar | 15(25%) | 5(33.3%) | 10(66.6%) | 0.068 |
Spinal cord | 3(5%) | 2(66.6%) | 1(33.3%) | 1 |
Optic pathway | 2(3.3%) | 0 | 2(100%) | 0.18 |
Pathology | ||||
PAs | 31(51.6%) | 23(74.2%) | 8(25.8%) | 0.008* |
PMAs | 15(25%) | 9(60%) | 6(40%) | 0.769 |
DAs | 3(5%) | 0 | 3(100%) | |
PXA | 2(3.3%) | 0 | 2(100%) | |
LGGN | 9(15%) | 2(22.2%) | 7(77.7%) | 0.032* |
Gender | ||||
Females | 26(43.3%) | 16(61.5%) | 10(38.4%) | 0.79 |
Males | 34(56.5%) | 19(55.8%) | 15(44.1%) |